Text Registration
Copyright Title
Re-Evaluation Note
Status
Published
on 3 Oct 2019
Year of Creation
2009
Copyright Claimant
Bardavon Health Innovations, LLC
Registration Number
TX0008800901
on 3 Oct 2019Copyright Summary
The U.S. Copyright record (Registration Number: TX0008800901) dated 3 Oct 2019, pertains to an electronic file (eService) titled "Re-Evaluation Note" created in 2009. The copyright holder is Bardavon Health Innovations, LLC, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Bardavon Health Innovations, LLC.
Application Details
Registration Number
TX0008800901
Registration Date
10/3/2019
Year of Creation
2009
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Bardavon Health Innovations, LLC
Physical Description
Electronic file (eService)
First Publication Nation
United States
Notes
Rights Note: Amy Brozenic, Lathrop Gage LLP, 10851 Mastin Boulevard, Building 82, Suite 1000, Overland Park, KS, 66210-1669, United States, (913) 451-5100, ipdocketing@lathropgage.com
Statements
Application Title Statement: Re-Evaluation Note
Author Statement: Bardavon Health Innovations, LLC employer for hire Citizenship: United States Authorship: text
© 2023 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.